Department of Law, The Centre for Social Ethics and Policy, University of Manchester, Manchester, United Kingdom of Britain and Northern Ireland.
Centre for Medical Ethics, University of Oslo, Oslo, Norway.
Bioethics. 2022 Sep;36(7):742-756. doi: 10.1111/bioe.13047. Epub 2022 May 9.
In the debates regarding the ethics of human organoid biobanking, the locus of donor autonomy has been identified in processes of consent. The problem is that, by focusing on consent, biobanking processes preclude adequate engagement with donor autonomy because they are unable to adequately recognize or respond to factors that determine authentic choice. This is particularly problematic in biobanking contexts associated with organoid research or the clinical application of organoids because, given the probability of unforeseen and varying purposes for which a donor's organoids could be employed and given the different ways in which a donor can relate to her biospecimens, a donor can value her organoids differently in different contexts, and her reasons for autonomously permitting use of her cells and tissues in one case may not support an autonomous decision in another. In response, this paper has three aims: first, to make the case for why organoid biobanks ought to respect donor autonomy conceived as authentic choice; second, to explore the autonomy-respecting limits of established and widely prevalent models of biobank consent; and third, to propose certain conditions that organoid biobanks ought to support or facilitate in order to respect donor autonomy.
在关于人类类器官生物库伦理的争论中,供体自主性的中心问题已经在同意过程中得到确认。问题在于,由于专注于同意,生物库过程排除了对供体自主性的充分参与,因为它们无法充分认识或回应决定真实选择的因素。在与类器官研究或类器官的临床应用相关的生物库背景下,这尤其成问题,因为考虑到供体的类器官可能被用于无法预见和不断变化的目的的可能性,以及供体与她的生物样本相关的不同方式,供体在不同的情况下可能对她的类器官有不同的价值,并且她在一种情况下自主允许使用她的细胞和组织的原因可能不支持另一种情况下的自主决策。有鉴于此,本文有三个目的:第一,说明为什么类器官生物库应该尊重被视为真实选择的供体自主性;第二,探讨既定的、广泛流行的生物库同意模式对自主性的尊重程度;第三,提出类器官生物库应该支持或促进的某些条件,以尊重供体自主性。